Sign in

CIK 0001833214

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SAB Biotherapeutics, Inc.

Sign in to watch
Ticker
SABS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
853899721
Phone
+1 305-845-2813
Business address
777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
Former names
Big Cypress Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-09-29 Moin Andrew Director Option exercise +1,740,000 $1.75 $3.0M 2,198,457
2025-09-29 Moin Andrew Director Option exercise · Series B Convertible Preferred Stock −17,400 211,100
2025-07-22 Moin Andrew Director Grant or award · Series B Convertible Preferred Stock +228,500 228,500
2025-07-22 Moin Andrew Director Grant or award · Warrants (right to buy) +228,500 228,500
2025-07-22 Moin Andrew Director Grant or award · Warrants (right to buy) +114,250 114,250
2023-11-24 Moin Andrew Director Option exercise +4,584,571 4,584,571
2023-11-24 Moin Andrew Director Option exercise · Series A-1 Convertible Preferred Stock −31,269 $1,000.00 $31.3M 0
2023-11-24 Moin Andrew Director Option exercise · Series A-2 Convertible Preferred Stock +28,380 $1,000.00 $28.4M 28,380
2023-11-13 Moin Andrew Director Grant or award · Series A-1 Convertible Preferred Stock +13,269 $1,000.00 $13.3M 31,269
2023-11-13 Moin Andrew Director Option exercise · Preferred Tranche A Warrants −13,269 0
2023-11-13 Moin Andrew Director Grant or award · Series A-1 Convertible Preferred Stock +13,269 $1,000.00 $13.3M 13,269
2023-11-10 Moin Andrew Director Grant or award · Preferred Tranche A Warrants +13,269 13,269
2023-11-10 Moin Andrew Director Grant or award · Preferred Tranche B Warrants +8,846 20,846
2023-11-10 Moin Andrew Director Grant or award · Preferred Tranche C Warrants +22,115 52,115
2023-10-23 Moin Andrew Director Grant or award · Series A-1 Convertible Preferred Stock +16,269 $1,000.00 $16.3M 18,000
2023-10-23 Moin Andrew Director Option exercise · Preferred Tranche A Warrants −16,269 0

Page 1 of 1 · 16 trades